4.8 Review

Genetics of Human Cardiovascular Disease

Journal

CELL
Volume 148, Issue 6, Pages 1242-1257

Publisher

CELL PRESS
DOI: 10.1016/j.cell.2012.03.001

Keywords

-

Funding

  1. NHLBI/NIH
  2. Foundation Leducq
  3. Massachusetts General Hospital
  4. Pfizer
  5. Merck
  6. Alnylam
  7. Shire Therapeutics
  8. California Institute for Regenerative Medicine
  9. Younger Family Foundation
  10. Roddenberry Foundation
  11. Whittier Foundation

Ask authors/readers for more resources

Cardiovascular disease encompasses a range of conditions extending from myocardial infarction to congenital heart disease, most of which are heritable. Enormous effort has been invested in understanding the genes and specific DNA sequence variants that are responsible for this heritability. Here, we review the lessons learned for monogenic and common, complex forms of cardiovascular disease. We also discuss key challenges that remain for gene discovery and for moving from genomic localization to mechanistic insights, with an emphasis on the impact of next-generation sequencing and the use of pluripotent human cells to understand the mechanism by which genetic variation contributes to disease.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available